These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fluorescence polarization immunoassay evaluated for screening for amphetamine and methamphetamine in urine. Caplan YH, Levine B, Goldberger B. Clin Chem; 1987 Jul; 33(7):1200-2. PubMed ID: 3297420 [Abstract] [Full Text] [Related]
4. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing. Woodworth A, Saunders AN, Koenig JW, Moyer TP, Turk J, Dietzen DJ. Clin Chem; 2006 Apr; 52(4):743-6. PubMed ID: 16455869 [Abstract] [Full Text] [Related]
5. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods. Przekop MA, Manno JE, Kunsman GW, Cockerham KR, Manno BR. J Anal Toxicol; 1991 Apr; 15(6):323-6. PubMed ID: 1779660 [Abstract] [Full Text] [Related]
8. Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abuse of methamphetamine or amphetamine. Maurer HH, Kraemer T. Arch Toxicol; 1992 Apr; 66(9):675-8. PubMed ID: 1482291 [Abstract] [Full Text] [Related]
10. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. Dasgupta A, Saldana S, Kinnaman G, Smith M, Johansen K. Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030 [Abstract] [Full Text] [Related]
12. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers. Poklis A, Jortani SA, Brown CS, Crooks CR. J Anal Toxicol; 1993 Sep; 17(5):284-6. PubMed ID: 8107462 [Abstract] [Full Text] [Related]
13. Stereoisomeric identification of norephedrine derived from methamphetamine or amphetamine: urinalysis results of 33 methamphetamine abusers and 1 amphetamine abuser in Japan. Nagai T, Kido M, Maeda J, Matsushima K, Okazaki T, Kurosu A, Hitosugi M, Tokudome S. Anal Chem; 2007 Jun 01; 79(11):4177-81. PubMed ID: 17451226 [Abstract] [Full Text] [Related]
14. Response of EMIT amphetamine immunoassays to urinary desoxyephedrine following Vicks inhaler use. Poklis A, Moore KA. Ther Drug Monit; 1995 Feb 01; 17(1):89-94. PubMed ID: 7725384 [Abstract] [Full Text] [Related]
16. Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens. Hsu J, Liu C, Liu CP, Tsay WI, Li JH, Lin DL, Liu RH. J Anal Toxicol; 2003 Oct 01; 27(7):471-8. PubMed ID: 14607002 [Abstract] [Full Text] [Related]
17. Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry. Thurman EM, Pedersen MJ, Stout RL, Martin T. J Anal Toxicol; 1992 Oct 01; 16(1):19-27. PubMed ID: 1640694 [Abstract] [Full Text] [Related]
18. Amphetamine as an artifact of methamphetamine during periodate degradation of interfering ephedrine, pseudoephedrine, and phenylpropanolamine: an improved procedure for accurate quantitation of amphetamines in urine. Paul BD, Past MR, McKinley RM, Foreman JD, McWhorter LK, Snyder JJ. J Anal Toxicol; 1994 Oct 01; 18(6):331-6. PubMed ID: 7823540 [Abstract] [Full Text] [Related]